Annual Total Debt
$171.54 M
+$4.85 M+2.91%
31 December 2023
Summary:
Pharming Group NV annual total debt is currently $171.54 million, with the most recent change of +$4.85 million (+2.91%) on 31 December 2023. During the last 3 years, it has risen by +$9.59 million (+5.92%). PHAR annual total debt is now at all-time high.PHAR Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$127.08 M
+$5.06 M+4.15%
30 September 2024
Summary:
Pharming Group NV quarterly total debt is currently $127.08 million, with the most recent change of +$5.06 million (+4.15%) on 30 September 2024. Over the past year, it has dropped by -$36.90 million (-22.50%). PHAR quarterly total debt is now -25.92% below its all-time high of $171.54 million, reached on 31 December 2023.PHAR Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.9% | -22.5% |
| 3 y3 years | +5.9% | -22.9% |
| 5 y5 years | +105.6% | +91.8% |
PHAR Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +6.0% | -25.9% | +4.2% |
| 5 y | 5 years | at high | +194.8% | -25.9% | +118.4% |
| alltime | all time | at high | >+9999.0% | -25.9% |
Pharming Group NV Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $127.08 M(+4.1%) |
| June 2024 | - | $122.02 M(-27.0%) |
| Mar 2024 | - | $167.21 M(-2.5%) |
| Dec 2023 | $171.54 M(+2.9%) | $171.54 M(+4.6%) |
| Sept 2023 | - | $163.99 M(-3.6%) |
| June 2023 | - | $170.13 M(-0.2%) |
| Mar 2023 | - | $170.40 M(+2.2%) |
| Dec 2022 | $166.69 M(+3.0%) | $166.69 M(+19.8%) |
| Sept 2022 | - | $139.18 M(-6.6%) |
| June 2022 | - | $149.00 M(-5.6%) |
| Mar 2022 | - | $157.79 M(-2.5%) |
| Dec 2021 | $161.76 M(-0.1%) | $161.76 M(-1.8%) |
| Sept 2021 | - | $164.79 M(-3.3%) |
| June 2021 | - | $170.46 M(+11.0%) |
| Mar 2021 | - | $153.61 M(-5.2%) |
| Dec 2020 | $161.96 M(+178.3%) | $161.96 M(+6.1%) |
| Sept 2020 | - | $152.67 M(+5.3%) |
| June 2020 | - | $144.97 M(+3.3%) |
| Mar 2020 | - | $140.36 M(+141.2%) |
| Dec 2019 | $58.20 M(-30.2%) | $58.20 M(-12.1%) |
| Sept 2019 | - | $66.24 M(-11.2%) |
| June 2019 | - | $74.60 M(-7.0%) |
| Mar 2019 | - | $80.26 M(-3.8%) |
| Dec 2018 | $83.42 M(-15.4%) | $83.42 M(-7.7%) |
| Sept 2018 | - | $90.41 M(-6.4%) |
| June 2018 | - | $96.59 M(-0.3%) |
| Mar 2018 | - | $96.90 M(-1.8%) |
| Dec 2017 | $98.63 M(+39.2%) | $98.63 M(-5.0%) |
| Sept 2017 | - | $103.85 M(+0.3%) |
| June 2017 | - | $103.52 M(+47.7%) |
| Mar 2017 | - | $70.09 M(-1.1%) |
| Dec 2016 | $70.88 M | $70.88 M(+313.8%) |
| Sept 2016 | - | $17.13 M(-3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $17.70 M(+1.3%) |
| Mar 2016 | - | $17.47 M(+0.7%) |
| Dec 2015 | $17.35 M(+796.5%) | $17.35 M(-5.6%) |
| Sept 2015 | - | $18.38 M(+1381.4%) |
| June 2015 | - | $1.24 M(-5.9%) |
| Mar 2015 | - | $1.32 M(-31.9%) |
| Dec 2014 | $1.93 M(-29.0%) | $1.93 M(-0.9%) |
| Sept 2014 | - | $1.95 M(-13.9%) |
| June 2014 | - | $2.27 M(+1.5%) |
| Mar 2014 | - | $2.23 M(-18.0%) |
| Dec 2013 | $2.72 M(-27.9%) | $2.72 M(-58.2%) |
| Sept 2013 | - | $6.51 M(-44.5%) |
| June 2013 | - | $11.75 M(-25.7%) |
| Mar 2013 | - | $15.80 M(+318.4%) |
| Dec 2012 | $3.78 M(-15.1%) | $3.78 M(-4.1%) |
| Sept 2012 | - | $3.94 M(>+9900.0%) |
| June 2012 | - | $0.00(-100.0%) |
| Mar 2012 | - | $8.23 M(+85.1%) |
| Dec 2011 | $4.45 M(+4245.1%) | $4.45 M(>+9900.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(-100.0%) |
| Dec 2010 | $102.40 K(-99.7%) | $102.40 K(-99.3%) |
| Sept 2010 | - | $15.15 M(-64.0%) |
| June 2010 | - | $42.09 M(-13.5%) |
| Mar 2010 | - | $48.69 M(+46.3%) |
| Dec 2009 | $33.27 M(-57.8%) | $33.27 M(>+9900.0%) |
| Sept 2009 | - | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00 |
| Dec 2008 | $78.78 M(-2.7%) | - |
| Dec 2007 | $80.96 M(+3784.9%) | - |
| Dec 2006 | $2.08 M(+3493.1%) | - |
| Dec 2005 | $58.00 K | - |
FAQ
- What is Pharming Group NV annual total debt?
- What is the all time high annual total debt for Pharming Group NV?
- What is Pharming Group NV annual total debt year-on-year change?
- What is Pharming Group NV quarterly total debt?
- What is the all time high quarterly total debt for Pharming Group NV?
- What is Pharming Group NV quarterly total debt year-on-year change?
What is Pharming Group NV annual total debt?
The current annual total debt of PHAR is $171.54 M
What is the all time high annual total debt for Pharming Group NV?
Pharming Group NV all-time high annual total debt is $171.54 M
What is Pharming Group NV annual total debt year-on-year change?
Over the past year, PHAR annual total debt has changed by +$4.85 M (+2.91%)
What is Pharming Group NV quarterly total debt?
The current quarterly total debt of PHAR is $127.08 M
What is the all time high quarterly total debt for Pharming Group NV?
Pharming Group NV all-time high quarterly total debt is $171.54 M
What is Pharming Group NV quarterly total debt year-on-year change?
Over the past year, PHAR quarterly total debt has changed by -$36.90 M (-22.50%)